Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine, Paracetamol and Phenylephrine for Common Cold
NCT05070650Phase 3Withdrawn
- Sponsor
- Sandoz
- Start
- Sep 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acetylcysteine in common cold, sponsored by Sandoz. Planned start Sep 2024; status: withdrawn.
02
Drugs
acetylcysteine
03
Conditions
common cold
Beyond the preview
Go deeper on NCT05070650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05070650.